On Wednesday, January 28, 2026, more than 860 MedTech professionals registered for MedTech Leading Voice’s live webinar on post-market clinical follow-up, with over 400 attending live — a strong signal of how operationally urgent PMCF has become under the EU MDR.

The session, Real-Life PMCF: Practical Lessons, NB Insights and 2026 Priorities, brought together clinical and regulatory leaders working directly with MDR submissions and notified body reviews, including Daniela Karrer, VP Clinical Affairs and; Matteo Mosso, Director, Clinical Affairs at Donawa Lifescience; joined by Diane Legere, RN, BSN, MSc, APCCN, Senior Clinical Auditor at DNV Product Assurance AS.

A full replay of the webinar can be accessed from here, and a copy of the slide deck used can be downloaded from here.